Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

SELL
$0.54 - $1.41 $10,309 - $26,919
-19,092 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$1.4 - $5.15 $2,970 - $10,928
-2,122 Reduced 10.0%
19,092 $28,000
Q4 2021

Feb 11, 2022

BUY
$4.27 - $6.97 $4,492 - $7,332
1,052 Added 5.22%
21,214 $111,000
Q3 2021

Nov 04, 2021

SELL
$5.31 - $8.25 $2,978 - $4,628
-561 Reduced 2.71%
20,162 $118,000
Q2 2021

Aug 11, 2021

SELL
$6.81 - $9.23 $4,453 - $6,036
-654 Reduced 3.06%
20,723 $167,000
Q1 2021

May 13, 2021

SELL
$7.99 - $15.0 $15,452 - $29,010
-1,934 Reduced 8.3%
21,377 $177,000
Q4 2020

Feb 16, 2021

BUY
$7.04 - $11.7 $46,527 - $77,325
6,609 Added 39.57%
23,311 $177,000
Q3 2020

Nov 12, 2020

BUY
$9.98 - $18.04 $8,682 - $15,694
870 Added 5.5%
16,702 $178,000
Q2 2020

Aug 13, 2020

BUY
$7.49 - $15.16 $47,441 - $96,023
6,334 Added 66.69%
15,832 $240,000
Q1 2020

May 14, 2020

SELL
$4.62 - $18.74 $1,972 - $8,001
-427 Reduced 4.3%
9,498 $79,000
Q4 2019

Feb 14, 2020

BUY
$14.6 - $18.13 $30,046 - $37,311
2,058 Added 26.16%
9,925 $167,000
Q3 2019

Nov 14, 2019

SELL
$16.62 - $23.92 $141,851 - $204,157
-8,535 Reduced 52.04%
7,867 $145,000
Q2 2019

Aug 14, 2019

SELL
$17.79 - $22.88 $299,921 - $385,733
-16,859 Reduced 50.69%
16,402 $373,000
Q1 2019

May 15, 2019

SELL
$11.76 - $22.15 $5,139 - $9,679
-437 Reduced 1.3%
33,261 $697,000
Q4 2018

Feb 14, 2019

SELL
$10.42 - $21.94 $289,269 - $609,076
-27,761 Reduced 45.17%
33,698 $386,000
Q3 2018

Dec 21, 2021

BUY
$20.4 - $24.6 $139,638 - $168,387
6,845 Added 12.53%
61,459 $1.41 Million
Q3 2018

Nov 14, 2018

BUY
$20.4 - $24.6 $62,240 - $75,054
3,051 Added 5.92%
54,614 $1.25 Million
Q2 2018

Apr 21, 2020

BUY
$19.02 - $24.95 $190,352 - $249,699
10,008 Added 24.08%
51,563 $1.15 Million
Q2 2018

Aug 14, 2018

BUY
$19.02 - $24.95 $75,680 - $99,276
3,979 Added 10.59%
41,555 $926,000
Q1 2018

Oct 18, 2019

BUY
$22.55 - $29.9 $199,702 - $264,794
8,856 Added 30.84%
37,576 $858,000
Q1 2018

May 15, 2018

SELL
$22.55 - $29.9 $6.4 Million - $8.48 Million
-283,750 Reduced 90.81%
28,720 $656,000
Q4 2017

Feb 14, 2018

BUY
$18.0 - $30.0 $5.2 Million - $8.67 Million
289,098 Added 1236.94%
312,470 $8.19 Million
Q3 2017

Nov 14, 2017

BUY
$21.1 - $25.15 $493,149 - $587,805
23,372
23,372 $523,000

Others Institutions Holding AXDX

About Accelerate Diagnostics, Inc


  • Ticker AXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 99,059,904
  • Market Cap $191M
  • Description
  • Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...
More about AXDX
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.